152 related articles for article (PubMed ID: 24029417)
1. Preclinical evaluation of a new liposomal formulation of cisplatin, lipoplatin, to treat cisplatin-resistant cervical cancer.
Casagrande N; De Paoli M; Celegato M; Borghese C; Mongiat M; Colombatti A; Aldinucci D
Gynecol Oncol; 2013 Dec; 131(3):744-52. PubMed ID: 24029417
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of gold(III)-dithiocarbamato derivatives on prostate cancer cells and xenografts.
Cattaruzza L; Fregona D; Mongiat M; Ronconi L; Fassina A; Colombatti A; Aldinucci D
Int J Cancer; 2011 Jan; 128(1):206-15. PubMed ID: 20209498
[TBL] [Abstract][Full Text] [Related]
3. Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species.
Yang YI; Kim JH; Lee KT; Choi JH
Gynecol Oncol; 2011 Dec; 123(3):588-96. PubMed ID: 21945308
[TBL] [Abstract][Full Text] [Related]
4. Standardized flavonoid-rich fraction of Artemisia princeps Pampanini cv. Sajabal induces apoptosis via mitochondrial pathway in human cervical cancer HeLa cells.
Ju HK; Lee HW; Chung KS; Choi JH; Cho JG; Baek NI; Chung HG; Lee KT
J Ethnopharmacol; 2012 May; 141(1):460-8. PubMed ID: 22449440
[TBL] [Abstract][Full Text] [Related]
5. Activity of lipoplatin in tumor and in normal cells in vitro.
Arienti C; Tesei A; Ravaioli A; Ratta M; Carloni S; Mangianti S; Ulivi P; Nicoletti S; Amadori D; Zoli W
Anticancer Drugs; 2008 Nov; 19(10):983-90. PubMed ID: 18827563
[TBL] [Abstract][Full Text] [Related]
6. Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer.
Sreekanth CN; Bava SV; Sreekumar E; Anto RJ
Oncogene; 2011 Jul; 30(28):3139-52. PubMed ID: 21317920
[TBL] [Abstract][Full Text] [Related]
7. A novel polysaccharide, isolated from Angelica sinensis (Oliv.) Diels induces the apoptosis of cervical cancer HeLa cells through an intrinsic apoptotic pathway.
Cao W; Li XQ; Wang X; Fan HT; Zhang XN; Hou Y; Liu SB; Mei QB
Phytomedicine; 2010 Jul; 17(8-9):598-605. PubMed ID: 20092988
[TBL] [Abstract][Full Text] [Related]
8. Clinical overview on Lipoplatin: a successful liposomal formulation of cisplatin.
Boulikas T
Expert Opin Investig Drugs; 2009 Aug; 18(8):1197-218. PubMed ID: 19604121
[TBL] [Abstract][Full Text] [Related]
9. Salinomycin induces apoptosis in cisplatin-resistant colorectal cancer cells by accumulation of reactive oxygen species.
Zhou J; Li P; Xue X; He S; Kuang Y; Zhao H; Chen S; Zhi Q; Guo X
Toxicol Lett; 2013 Oct; 222(2):139-45. PubMed ID: 23916687
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.
Chen Y; Ke G; Han D; Liang S; Yang G; Wu X
Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997
[TBL] [Abstract][Full Text] [Related]
11. The synthetic flavonoid WYC02-9 inhibits cervical cancer cell migration/invasion and angiogenesis via MAPK14 signaling.
Chen YJ; Cheng YJ; Hung AC; Wu YC; Hou MF; Tyan YC; Yuan SS
Gynecol Oncol; 2013 Dec; 131(3):734-43. PubMed ID: 24145114
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin-alginate conjugate liposomes for targeted delivery to EGFR-positive ovarian cancer cells.
Wang Y; Zhou J; Qiu L; Wang X; Chen L; Liu T; Di W
Biomaterials; 2014 May; 35(14):4297-309. PubMed ID: 24565522
[TBL] [Abstract][Full Text] [Related]
13. [Reversion of resistance to cisplatin induced by MG132 in cervical cancer line HCE1 multicellular spheroid].
Wu YL; Yang HJ; Wang KK; Tao GS; Liu YZ; Hu Y
Zhonghua Fu Chan Ke Za Zhi; 2010 Apr; 45(4):287-91. PubMed ID: 20646542
[TBL] [Abstract][Full Text] [Related]
14. Low toxicity and anticancer activity of a novel liposomal cisplatin (Lipoplatin) in mouse xenografts.
Boulikas T
Oncol Rep; 2004 Jul; 12(1):3-12. PubMed ID: 15201951
[TBL] [Abstract][Full Text] [Related]
15. Nrf2 knockdown by shRNA inhibits tumor growth and increases efficacy of chemotherapy in cervical cancer.
Ma X; Zhang J; Liu S; Huang Y; Chen B; Wang D
Cancer Chemother Pharmacol; 2012 Feb; 69(2):485-94. PubMed ID: 21842204
[TBL] [Abstract][Full Text] [Related]
16. 2a, a novel curcumin analog, sensitizes cisplatin-resistant A549 cells to cisplatin by inhibiting thioredoxin reductase concomitant oxidative stress damage.
Zhou B; Huang J; Zuo Y; Li B; Guo Q; Cui B; Shao W; Du J; Bu X
Eur J Pharmacol; 2013 May; 707(1-3):130-9. PubMed ID: 23524096
[TBL] [Abstract][Full Text] [Related]
17. Aldehyde dehydrogenase high gastric cancer stem cells are resistant to chemotherapy.
Nishikawa S; Konno M; Hamabe A; Hasegawa S; Kano Y; Ohta K; Fukusumi T; Sakai D; Kudo T; Haraguchi N; Satoh T; Takiguchi S; Mori M; Doki Y; Ishii H
Int J Oncol; 2013 Apr; 42(4):1437-42. PubMed ID: 23440340
[TBL] [Abstract][Full Text] [Related]
18. Naringin induces death receptor and mitochondria-mediated apoptosis in human cervical cancer (SiHa) cells.
Ramesh E; Alshatwi AA
Food Chem Toxicol; 2013 Jan; 51():97-105. PubMed ID: 22847135
[TBL] [Abstract][Full Text] [Related]
19. EGF receptor and p21WAF1 expression are reciprocally altered as ME-180 cervical carcinoma cells progress from high to low cisplatin sensitivity.
Donato NJ; Perez M; Kang H; Siddik ZH; Ling YH; Perez-Soler R
Clin Cancer Res; 2000 Jan; 6(1):193-202. PubMed ID: 10656450
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of stemlike cells in human esophageal adenocarcinoma and normal epithelial cell lines.
Zhao R; Quaroni L; Casson AG
J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1192-9. PubMed ID: 22980068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]